ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Jazz' small cell lung cancer therapy wins US green light pharmatimes
June 17, 2020Jazz Pharmaceuticals and PharmaMar have announced US approval of Zepzelca (lurbinectedin) for the treatment of adults with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.
Pharma Sources Insight January 2025
